Caspian Journal of Internal Medicine
Babol University of Medical Sciences
Fri, Feb 21, 2025
[Archive]
Volume 15, Issue 4 (Autumn 2024)
Caspian J Intern Med 2024, 15(4): 713-728 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Bozorgmehr R, Esmaili Tarki F, Yazdi E, Shahrokhi Nejad S. COVID-19 associated lung cavitary lesions: A case series. Caspian J Intern Med 2024; 15 (4) :713-728
URL: http://caspjim.com/article-1-4050-en.html
URL: http://caspjim.com/article-1-4050-en.html
Shahid Beheshti University of Medical Sciences, Tehran, Iran , shery.1375.sh@gmail.com
Abstract: (636 Views)
Background: Our study discusses the probable etiologies and characteristics of pulmonary cavities in post-COVID-19 patients. A pulmonary cavity is a late complication of the disease, yet it has led to multiple referrals to our tertiary hospital in Tehran, Iran.
Methods: We conducted a retrospective case-series study on 20 patients who were admitted to our center between April 2020 and September 2021. They were all diagnosed with COVID-19 and concomitantly developed pulmonary cavities. We assessed their electronic medical records in 2021 and compared their characteristics with other studies based on the available literature.
Result: Of the 20 patients with cavities, 12 (60%) had been diagnosed with prior COVID-19, and 9 (45%) had type 2 diabetes mellitus. 9 patients (45%) had bacterial superinfections while 4 (44%) had fungal infections. All patients received corticosteroids, but only 4 (20%) were additionally administered Tocilizumab.
Conclusion: COVID-19 patients can develop pulmonary cavities during recovery; however, this infrequent radiologic finding depends on specific risk factors.
Methods: We conducted a retrospective case-series study on 20 patients who were admitted to our center between April 2020 and September 2021. They were all diagnosed with COVID-19 and concomitantly developed pulmonary cavities. We assessed their electronic medical records in 2021 and compared their characteristics with other studies based on the available literature.
Result: Of the 20 patients with cavities, 12 (60%) had been diagnosed with prior COVID-19, and 9 (45%) had type 2 diabetes mellitus. 9 patients (45%) had bacterial superinfections while 4 (44%) had fungal infections. All patients received corticosteroids, but only 4 (20%) were additionally administered Tocilizumab.
Conclusion: COVID-19 patients can develop pulmonary cavities during recovery; however, this infrequent radiologic finding depends on specific risk factors.
Keywords: COVID-19, thoracic cavity, lung, Aspergillosis, pulmonary cavity, post COVID-19 cavity, COVID-19 complications, COVID-19 rare presentations
Type of Study: Case Series |
Subject:
Pulmonology
Received: 2023/08/14 | Accepted: 2023/11/7 | Published: 2024/08/29
Received: 2023/08/14 | Accepted: 2023/11/7 | Published: 2024/08/29
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
